BioCentury
ARTICLE | Clinical News

Amturnide regulatory update

January 3, 2011 8:00 AM UTC

Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Product: Amturnide Business: Cardiovascular FDA approved an NDA from Novartis for Amturnide to treat hypertension in patients not adequately contr...